Semaglutide – 9.6mg Pen

$400.00

Semaglutide – 9.6mg Pen

$400.00

WEGOVY 2.4MG/DOSE PREFILLED PEN – CANADIAN PHARMACEUTICAL GRADE SEMAGLUTIDE INJECTION

Wegovy (Semaglutide) 2.4mg/dose is a Canadian pharmaceutical grade GLP-1 receptor agonist provided in a prefilled injectable pen for precise, single-dose administration. It is widely used in research to study metabolic regulation, glucose homeostasis, and energy balance pathways.

This high-quality formulation delivers consistent dosage accuracy and stability for long-term experimental use, allowing researchers to evaluate the physiological effects of GLP-1 receptor activation on metabolic and appetite-related mechanisms.

The Details:

Dosage: 2.4mg semaglutide per dose
Form: Prefilled injection pen
Quantity: Single-use pen, ready for controlled application
Packaging: Sterile, tamper-evident pen in sealed packaging
Source: Canadian pharmaceutical grade, third-party tested for purity and consistency

Key Features of Wegovy 2.4mg:

Metabolic Regulation Research: Supports studies on energy homeostasis and glucose signaling.
GLP-1 Pathway Analysis: Enables examination of incretin-related receptor pathways.
Dose Precision: Prefilled delivery system ensures reliable and reproducible dosing.
Appetite and Energy Studies: Investigated for effects on satiety and caloric intake regulation.
Pharmaceutical Authenticity: Canadian-produced and independently verified.

Categories: Peptide Pens, Peptides

Description

Description

Semaglutide 9.6mg Pen is a premium GLP-1 receptor agonist supplied in a prefilled delivery system designed for precision, consistency, and controlled handling. Each unit is manufactured under strict quality control standards to ensure uniform composition, stability, and reliable batch performance. Each dose is 2.4mg.

Semaglutide is widely referenced in metabolic and endocrine research contexts involving GLP-1 receptor signaling pathways and appetite regulation mechanisms. The pen format provides a structured and convenient delivery system for consistent dosing control.

Key Features:

GLP-1 Receptor Agonist: Semaglutide compound
9.6mg Total Content: Precisely measured formulation
Prefilled Pen System: Convenient, controlled delivery format
Pharmaceutical Grade Quality: Manufactured to strict standards
Stable Composition: Designed for batch reliability and consistency
Secure Packaging: Sealed pen system for product integrity

Each pen is clearly labeled with full specifications for easy identification and comparison. This product is intended for research and pharmaceutical reference purposes and is supplied in a premium format for consistent sourcing and verified composition.

Wolverine Pen 50mg (BPC157 / TB500)

GLP-3 RTA Triple G Pen 40mg – Adjustable Dose